FiercePharma  Jun 1  Comment 
The 2-mg dose of Eli Lilly and Incyte's rheumatoid arthritis drug Olumiant picked up an FDA approval after independent experts flagged safety concerns on the 4-mg dose. And with a black-box warning on its label, the new drug will face an uphill...
FiercePharma  May 24  Comment 
Eli Lilly is leaning on oncology as a key pillar for growth going forward, but with news that its president of the business, Sue Mahony, is retiring, the drugmaker will need to find new leadership for the unit.
GenEng News  May 10  Comment 
Eli Lilly plans to acquire Armo BioSciences for approximately $1.6 billion, the companies said today, in a deal that builds the buyer’s immuno-oncology pipeline with a Phase III pancreatic cancer candidate that is also being developed to treat...
Motley Fool  Apr 25  Comment 
Lilly's first-quarter results looked good. Is it time to buy the big pharma stock?
FiercePharma  Apr 24  Comment 
It's been a good news-bad news 24 hours for Eli Lilly. Its closely watched RA prospect baricitinib didn't exactly sail through Monday's FDA committee meeting. But Tuesday morning, Lilly rolled out first-quarter results that beat sales and earnings...
Reuters  Apr 24  Comment 
Eli Lilly and Co on Tuesday beat analysts' profit estimates for the fifth straight quarter and raised its 2018 forecasts on higher demand for newer drugs including diabetes drug Trulicity and psoriasis medicine Taltz.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki